Page 234 - Strategies for non-invasive managementof high-grade cervical intraepithelial neoplasia - prognostic biomarkers and immunotherapy Margot Maria Koeneman
P. 234
Publications
Koeneman MM, Hendriks N, Kooreman LFS, Winkens B, Kruitwagen RFPM, Kruse AJ. Smoking status and parity are associated with spontaneous regression of high-risk HPV-positive CIN2. Submitted
Koeneman MM, Ovestad IT, Schellekens J, Munk AC, Janssen EAM, Tilanus MGJ, Kruitwagen RFPM, Kruse AJ. A common epitope in HLA- DRB1*13/14 may protect against HPV16 related high- grade cervical intraepithelial neoplasia. Submitted
Koeneman MM, Ovestad IT, Janssen EAM, Ummelen M, Kruitwagen RFPM, Hopman AH, Krüse AJ. Gain of chromosomal region 3q26 as a prognostic biomarker for high-grade cervical intraepithelial neoplasia: literature overview and pilot study.
Pathology & Oncology Research. 2018 Oct 25
van de Sande AJM, Koeneman MM, Gerestein CG, Kruse AJ, van Kemenade FJ, van Beekhuizen HJ. TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.BMC Cancer. 2018 Jun 15;18(1):655.
Koeneman MM, Essers BA, Gerestein CG, van de Sande AJM, Litjens RJNTM, Boskamp D, Goossens MFJ, Beekhuizen HJ, Kruitwagen RFPM, Kruse AJ, Dirksen CD. Treatment of Cervical Intraepithelial Neoplasia: Patients Preferences for Surgery or Immunotherapy with Imiquimod. Journal of Immunotherapy. 2017 Feb; 40 (4): 148-153.
Koeneman MM, Kruse AJ, Kooreman LF, Zur Hausen A, Hopman AH, Sep SJ, Van Gorp T, Slangen BF, van Beekhuizen HJ, van de Sande AJ, Gerestein CG, Nijman HW, Kruitwagen RF. Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial. BMC Cancer. 2017 Feb 7;17(1):110.
Koeneman MM, van Lint FH, van Kuijk SM, Smits LJ, Kooreman LF, Kruitwagen RF, Kruse AJ. A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parameters. Hum Pathol. 2016 Sep 30.
Koeneman MM, Heiligers-Duckers C, Van der Velde R, Wouda S, De Rooij MJM, Janssen MJW, Boskamp D. Ovarian Leydig cell hyperplasia as a rare cause of hair loss in a postmenopausal female patient: a case report and diagnostic approach towards postmenopausal hyperandrogenism. Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:198-200
Koeneman MM, Kruse AJ, Kooreman LF, Zur Hausen A, Hopman AH, Sep SJ, Van Gorp T, Slangen BF, van Beekhuizen HJ, van de Sande M, Gerestein CG, Nijman HW, Kruitwagen RF.TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial. BMC Cancer. 2016 Feb 20;16(1):132
232